[go: up one dir, main page]

WO2000041671A3 - Composition, dispositif, et methode pour retirer des matieres adipeuses sous cutanees - Google Patents

Composition, dispositif, et methode pour retirer des matieres adipeuses sous cutanees Download PDF

Info

Publication number
WO2000041671A3
WO2000041671A3 PCT/US1999/029374 US9929374W WO0041671A3 WO 2000041671 A3 WO2000041671 A3 WO 2000041671A3 US 9929374 W US9929374 W US 9929374W WO 0041671 A3 WO0041671 A3 WO 0041671A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
subcutaneous fat
fat removal
skin
topical application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/029374
Other languages
English (en)
Other versions
WO2000041671A2 (fr
WO2000041671A9 (fr
Inventor
Nikolai Tankovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
T & T Pharmaceuticals Ltd
Original Assignee
T & T Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T & T Pharmaceuticals Ltd filed Critical T & T Pharmaceuticals Ltd
Publication of WO2000041671A2 publication Critical patent/WO2000041671A2/fr
Publication of WO2000041671A3 publication Critical patent/WO2000041671A3/fr
Anticipated expiration legal-status Critical
Publication of WO2000041671A9 publication Critical patent/WO2000041671A9/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/89Suction aspects of liposuction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84Drainage tubes; Aspiration tips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/0476Oxygenated solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/08Lipoids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/05General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/058General characteristics of the apparatus combined with other kinds of therapy with ultrasound therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une composition particulière, un dispositif et une méthode permettant de dissoudre des matières adipeuses associées à la peau, ou situées près de la peau. Cette composition concerne des compositions perfluorocarbonées, les dispositifs comprennent des perfluorocarbones pour une application topique sur la peau, et les méthodes comprennent l'injection sous-cutanée ou l'application topique de compositions perfluorocarbonées.
PCT/US1999/029374 1999-01-12 1999-12-09 Composition, dispositif, et methode pour retirer des matieres adipeuses sous cutanees Ceased WO2000041671A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23170599A 1999-01-12 1999-01-12
US09/231,705 1999-01-12

Publications (3)

Publication Number Publication Date
WO2000041671A2 WO2000041671A2 (fr) 2000-07-20
WO2000041671A3 true WO2000041671A3 (fr) 2000-11-23
WO2000041671A9 WO2000041671A9 (fr) 2002-04-11

Family

ID=22870339

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029374 Ceased WO2000041671A2 (fr) 1999-01-12 1999-12-09 Composition, dispositif, et methode pour retirer des matieres adipeuses sous cutanees

Country Status (1)

Country Link
WO (1) WO2000041671A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888101B1 (fr) 2005-06-06 2012-03-21 Georgetown University Compositions et procedes de lipomodelage
US10980925B1 (en) 2008-10-14 2021-04-20 A Hoyos Llc High definition liposculpture
US9888933B1 (en) * 2008-10-14 2018-02-13 Alfredo Ernesto Hoyos Ariza Vaser assisted high definition liposculpture
FR2937554B1 (fr) * 2008-10-27 2010-11-12 Yves Crassas Solutions salines aqueuses pour la destruction de tissus graisseux
USD883767S1 (en) 2018-10-10 2020-05-12 A Hoyos Llc Handle

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455373A (en) * 1994-02-28 1995-10-03 Exfluor Research Corporation Method of producing perfluorocarbon halides
US5637318A (en) * 1992-06-26 1997-06-10 Lancaster Group Ag Dermatological agent for assisting the transport of oxygen in the skin
US5679459A (en) * 1992-06-03 1997-10-21 Alliance Pharmaceutical Corp. Perfluorinated amphiphilic phosphorous compounds: liposomal compositions
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5679459A (en) * 1992-06-03 1997-10-21 Alliance Pharmaceutical Corp. Perfluorinated amphiphilic phosphorous compounds: liposomal compositions
US5637318A (en) * 1992-06-26 1997-06-10 Lancaster Group Ag Dermatological agent for assisting the transport of oxygen in the skin
US5455373A (en) * 1994-02-28 1995-10-03 Exfluor Research Corporation Method of producing perfluorocarbon halides
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine

Also Published As

Publication number Publication date
WO2000041671A2 (fr) 2000-07-20
WO2000041671A9 (fr) 2002-04-11

Similar Documents

Publication Publication Date Title
WO2002028425A3 (fr) Procedes de traitement de lesions musculaires
AU3311095A (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
EP1570840A3 (fr) Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle
ATE244558T1 (de) Trockene formbare arzneistoffformulierung
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
WO2002003952A3 (fr) Composition pour le soin de la peau contenant des elastomeres de silicone
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
WO2003002175A8 (fr) Profil pharmacocinetique ameliore de substances administrees par voie intradermique
WO2001074307A3 (fr) Compositions et procedes de traitement de la chute des cheveux au moyen de prostaglandines oxymyle et hydroylamino
WO2000041528A3 (fr) Compositions a liberation controlee amelioree et son procede
WO2005037323A3 (fr) Methode pour inhiber une signalisation de nf-kappa b et son utilisation pour traiter et pour prevenir des maladies humaines
WO2004052308A3 (fr) Preparations antiinfectieuses topiques
WO2006083979A3 (fr) Traitement local des neurofibromes
EP1338270A3 (fr) Utilisation dans un traitement cosmétique d'une fraction phénolique riche en dihydrochalcones
AU5916990A (en) Preparations for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
WO2000041671A3 (fr) Composition, dispositif, et methode pour retirer des matieres adipeuses sous cutanees
WO2004054557A3 (fr) Traitement de la mastalgie a l'aide de 4-hydroxy tamoxifene
CA2294950A1 (fr) Levobupivacaine et son utilisation
EP0900561A4 (fr) Composition favorisant la production de collagene
WO2003007900A3 (fr) Traitement de la peau
EP1621207A3 (fr) Composition de défibrotide et de G-CSF et son utilisation pour l'activation des progéniteurs hématopoiétiques
BR0107544A (pt) Composição de promoção de secreção de bile
EP0693479A4 (fr) Nouveau compose du type aconitine, agent antipyretique, analgesique et anti-inflammatoire
WO1999047105A3 (fr) Formulation pour la peau hydratante, antimicrobienne et liquide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): BR CA CN IL JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 4/5-5/5, DRAWINGS, REPLACED BY NEW PAGES 4/5-5/5; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase